Managers

February IPO profiles: Drugmaker Gossamer Bio leads the way

Sherlock Biosciences launches with $35 mln capital

Sherlock Biosciences said March 21 that it has launched with $35 million in committed capital. This includes a $17.5 million non-dilutive grant and an investment from the Open Philanthropy Project. Sherlock, of Cambridge, Massachusetts, is an engineering biology company that seeks to make testing better, faster and more affordable.

Founders Circle Capital is raising a second opportunities fund

Flagship Pioneering raises $824 mln for larger special opportunities fund, spun out four companies last year

February Dashboard: Fundraising was robust, but falls short of January's high watermark

Post Venture Capital Index gains ground in February

European firm Btov aims to take leading position in industrial tech

Green Visor Capital to raise $100 million venture-capital fund

Green Visor Capital has set out to raise a $100 million third venture-capital fund, according to a filing with the SEC.

Battery's Scott Tobin on immigrant entrepreneurs, VC in Israel

VCs on the Move: Monthly recap includes Y Combinator's Altman and more